¥»ºô¯¸¨ì³X¤H¼Æ¡G1011798
 
¥þ³¡¡U ªk«ß ¡U ©R¥O¡U ¦æ¬F³W«h¡U ¦æ¬F¨çÄÀ
 ²Ä 1 / 200 ­¶
  ¤U¤@­¶¢x ³Ì¥½­¶
¤½µo¥¬¤é
Ãþ§O
°T®§ºK­n
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡G­q©w¡u­¹«~·L¥Íª«¤§ÀËÅç¤èªk¡X¦×¬r±ìµß¤§ÀËÅç¡v¬°­¹«~½Ã¥ÍºÞ²zªk©Ò©w¤§­¹«~½Ã¥ÍÀËÅç¤èªk¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡G­q©w¡u­¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¸zª¢©·µß¤§ÀËÅç¡v¬°­¹«~½Ã¥ÍºÞ²zªk©Ò©w¤§­¹«~½Ã¥ÍÀËÅç¤èªk¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡G¼o¤î¡u­¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¦×¬r±ìµß¤Î¨ä¬r¯À¤§ÀËÅç¡v¡B¡u­¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¸zª¢©·µß¤§ÀËÅç¡v¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡G¼o¤î¡u­¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¦×¬r±ìµß¤Î¨ä¬r¯À¤§ÀËÅç¡v¡B¡u­¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¸zª¢©·µß¤§ÀËÅç¡v¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G­×¥¿¡u©I§lªvÀø®vªk¬I¦æ²Ó«h¡v
101.05.15
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G­q©w¡u¤¤ÃĬdÅçµn°O¼f¬d¶O¦¬¶O¼Ð·Ç¡v
101.05.14
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G­×¥¿¡u¤ÆùÛ«~§t¦³ÂåÀø©Î¬r¼@ÃÄ«~°ò·Ç¤¤¨¾Åξ¯¦¨¤ÀButyl methoxydibenzoyl methane¤§¨Ï¥Î­­¶qºÞ²z³W©w¡v¡A¦Û101¦~5¤ë14¤é¥Í®Ä
101.05.11
¦æ¬F³W«h
¦æ¬F°|½Ã¥Í¸p¤¤¥¡°·±d«OÀI§½¥O¡G­×¥¿¡u¥þ¥Á°·±d«OÀIÃÄ«~µ¹¥I³W©w¡X²Ä1³¹¯«¸g¨t²ÎÃĪ« Drugs acting on the nervous system 1.3.4.©¬ª÷´Ë¤ó¯gªvÀøÃÄ«~¡vµ¹¥I³W©w¡A¦Û101¦~6¤ë1¤é¥Í®Ä
101.05.10
¦æ¬F³W«h
¦æ¬F°|½Ã¥Í¸p¤¤¥¡°·±d«OÀI§½¥O¡G­×¥¿¡u¥þ¥Á°·±d«OÀIÃÄ«~µ¹¥I³W©w¡X²Ä2³¹¤ßŦ¦åºÞ¤ÎµÇŦÃĪ« 2.1.5.1.Dabigatran¡]¦pPradaxa¡^¡v³W©w¡A¦Û101¦~6¤ë1¤é¥Í®Ä
101.05.08
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G­×¥¿¡uÃÄ«~¬dÅçµn°O¼f¬d·Ç«h¡v³¡¤À±ø¤å